FdaApplication
ANDA 220232
Identifiers
- fda_app_no: ANDA220232
Properties
| Property | Value |
|---|---|
| applicant_name | LAURUS LABS LTD |
| application_type | ANDA |
| approval_date | 2026-03-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE | 200MG;EQ 25MG BASE;300MG | TABLET;ORAL |
1 product